SCI 收录中、日、印、韩四国生物医学期刊分析与比较

摘要

目的：通过分析国际化生物医学期刊的数量和质量，从期刊出版的角度评价各国的生物医学研究水平。方法通过对汤森路透的年度出版物———期刊引证报告（SCI 版）进行深入的检索和分析，获取中、日、印、韩四国生物医学期刊的基本情况，进行深入的统计和分析。结果中国生物医学期刊的数量在亚洲四国中最低，其占科技期刊总数的比例也是最低的，但中国的生物医学期刊的质量在亚洲四国却居于领先地位；中国的生物医学期刊影响因子明显高于日、印、韩三国。与日本相比，我国的生物医学各学科的期刊数量还有一定差距。结论我国高水平的生物医学期刊数量不多，应从数量和质量两个方面努力，使我国的生物医学期刊走向世界，提升我国在世界生物医学出版领域的地位。%Objective To analyze the number and quality of biomedical journals of different countries,so as to evaluate the situation of their biomedical research.Methods We searched and analyzed the Journal citation report published by Thomson Reuters. The information of biomedical journals of four countries:China,Japan,India,and South Korea,was collected,and was subjected to statistical analysis.Results It was found that China had the least number of biomedical journals,and it accounted for the lowest ratio of its total journals.However,the quality of Chinese biomedical journals was in the lead among the four countries.The impact factor of Chinese journals was obviously higher than those of the other three groups.Compared with Japan,the numbers of Chinese biomedical journals was less for different academic areas.Conclusion China has comparatively small number of SCI-indexed biomedical journals, and the situation should be improved from both number and quality aspects,so that our biomedical journal become a part of the interna-tional biomedical publishing community.